In the paper, the in vitro dissolution of borneol in 12 hours from 6 batches of optimized inhalant samples were investigated. As a new dosage form, the in vitro release apparatus of nasal inhalant was invented and a pushing bump was used according to the simulation of the nose expiration and inspiration. Based on the data of r2 in the profile and similar factor f2 from 6 linear release tendencies, a good controlled release and a zero order tendency were observed. It can be suggested that there is a good correlation between the in vitro controlled release and the nose steady self-controllable expiration and inspiration, which will contribute to the trend of insoluble volatile drug controlled release and the effect of quick absorption in nasal pulmonary delivery to cure severe or acute cardiovascular or lung diseases at patients' sleeping, such as angina or breathing obstruction. Also, it was concluded that the prescription composed of insoluble volatile drugs can be prepared to be nasal inhalant from which drugs can be absorbed through nose steady self-controllable inspiration to the lung then into the blood and have a great effectiveness improvement of bioavailability at night timing drug delivery system.
M. Shakeel, A. Trinidade, S. Jehan and K. W. Ah-See, “The Use of Complementary and Alternative Medicine by Patients Attending a General Otolaryngology Clinic: Can We Afford to Ignore It?” American Journal of Otolaryngology, Vol. 31, No. 4, 2010, pp. 252-260.
K. J. Hunt, H. F. Coelho, B. Wider, R. Perry, S. K. Hung, R. Terry and E. Ernst, “Complementary and Alternative Medicine Use in England: Results from a National Survey.” International Journal of Clinical Practice, Vol. 64, No. 11, 2010, pp. 1496-1502.
D. Jimbo, Y. Kimura, M. Taniguchi, M. Inoue and K. Urakami, “Effect of Aromatherapy on Patients with Alzheimer’s Disease.” Psychogeriatrics, Vol. 9, No. 4, 2009, pp. 173-179. doi:10.1111/j.1479-8301.2009.00299.x
L. Weinberg , D. Story , J. Nam and L. Mcnicol, “Pharmacoeconomics of Volatile Inhalational Anaesthetic Agents: An 11-Year Retrospective Analysis.” Anaesthesia and intensive care, Vol. 38, No. 5, 2010, pp. 849-854.
D. K. Conn and D. P. Seitz, “Advances in the Treatment of Psychi- Atric Disorders in Long-Term Care Homes.” Current Opinion in Psychiatry, Vol. 23, No. 6, 2010, pp. 516-521. doi:10.1097/YCO.0b013e32833efe56
L. Moss , M. Rouse , K. A. Wesnes and M. Moss, “Differential Effects of the Aromas of Salvia Species on Memory and Mood.” Human Psychopharmacology, Vol. 25, No. 5, 2010, pp. 388-396. doi:10.1002/hup.1129
H. W. Tsang and T. Y. Ho, “A Systematic Review on the Anxiolytic Effects of Aromatherapy on Rodents under Experimentally Induced Anxiety Models.” Reviews in the Neurosciences, Vol. 21, No. 2, 2010, pp. 141-152.
A. Supoken, T. Chaisrisawatsuk and B. Chumworathayi, “Proportion of Gynecologic Cancer Patients Using Complementary and Alternative Medicine.” Asian Pacific Journal of Cancer Prevention, Vol. 10, 2009, pp. 779-782.
S. T. Charlton, S. S. Davis and L. Illum, “Evaluation of Bioadhesive Polymer as Delivery Systems for Nose to Brain Delivery: In Vitro Characterisation Studies.” Journal of Controlled Release, Vol. 118, No. 2, 2007, pp. 225-234. doi:10.1016/j.jconrel.2006.12.014
B. Luppi, F. Bigucci, T. Cerchiara and V. Zecchi, “Chitosan- Based Hydrogels for Nasal Drug Delivery: From Inserts to Nanoparticles.” Expert Opinion on Drug Delivery, Vol. 7, No. 7, 2010, pp. 811-828.
P. Costa, “An Alternative Method to the Evaluation of Similarity Factor in Dissolution Testing.” International Journal of Pharmaceutics, Vol. 220, No. 2, 2001, pp. 77-83. doi:10.1016/S0378-5173(01)00651-2